That first moment of inspiration feels great. But it’s even better when you show that it’s right. We’ve got over 32,000 high-performance antibodies to help you reach that moment. Together, we move forward faster. https://bit.ly/3bFUoaO
About us
At Abcam, we believe the scientific community goes further, faster when we go there together. And to keep on making ground-breaking discoveries, we need to work together in new ways. That’s why we’re constantly innovating to help scientists drive their research forward by providing products and solutions that play an essential role in fundamental research, drug discovery, diagnostic and therapeutic applications. We started with a simple mission: to provide the best biological reagents to life scientists worldwide. Today, we help 750,000 researchers in over 130 countries deliver faster breakthroughs in areas like cancer, neurological disorders, infectious diseases, and metabolic disorders. Abcam is proud to be part of Danaher. Danaher is a global science and technology leader. Together we combine our capabilities to accelerate the real-life impact of tomorrow’s science and technology to improve human health. Abcam is proud to be part of Danaher. Danaher is a global science and technology leader. Together we combine our capabilities to accelerate the real-life impact of tomorrow’s science and technology to improve human health.
- Website
-
https://www.abcam.com/
External link for abcam
- Industry
- Biotechnology Research
- Company size
- 1,001-5,000 employees
- Headquarters
- Cambridge, Cambridgeshire
- Type
- Public Company
- Specialties
- antibodies, custom services, proteins, gene-edited cell lines, knockout cell lines, rabbit antibodies, immunoassays, biological reagents, monoclonal antibodies, research, drug discovery , diagnostics, RabMAb, and Life Sciences
Locations
Employees at abcam
Updates
-
📢 New publication alert! Our collaborators at @Weizmann Institute of Science use integrative spatial analysis techniques to reveal new insights into the cellular organization and role of hypoxia within glioblastomas, the most aggressive and most common brain cancer. Read the paper in @Cell Press to find out more: https://bit.ly/3yc3Yzz To find out more about the technical and scientific approach behind this paper, including choosing the right reagents and integrating them into the workflow – read our accompanying application note, here: https://lnkd.in/ePaqP2EH
-
“We take pride in knowing that we make a meaningful difference to our customers.” Ben Gordon, Logistics Manager. From the lab to logistics, all roles at Abcam play a part in supporting our customers. That’s because when you work at Abcam, no matter your team, we share a passion for bringing scientists one step closer to their next breakthrough. Click the link to learn more about our purpose and impact, and how you can get involved. https://bit.ly/4a9rOcs
-
Congratulations to Emily on reaching an incredible milestone of 10 years at Abcam! 🎉✨ Your dedication, talent, and passion have made a lasting impact. We are grateful to have you as part of our team. 🙌 We spoke to Emily to find out what she loved most about working for Abcam, and here’s what she said: “I’ve had a number of roles in Abcam since joining in 2014, all in Abcam’s Digital team. I currently lead the Digital Transformation Office, a team that acts as an information hub for all our digital products, projects and programmes. This role has given me the opportunity to be involved in some of Abcam’s most strategically important initiatives and have the privilege to work with so many talented people across all other functions in Abcam. I love the variety in my role and that every day brings a new opportunity to connect with people, solve challenges and collaborate on important topics.” Interested in joining our Digital team? Find out about the Digital Technology & Data jobs we have available here: https://lnkd.in/ePNbSEpH
Today I'm celebrating 10 years at abcam and what an incredible 10 years it's been. I've had the privilege to work alongside so many talented and passionate people (far too many to name here, but I appreciate you all!), I've had the opportunity to work on some of the most challenging and rewarding projects of my career, and I've learnt and grown as an individual and a leader. I'm continually grateful for these opportunities! #progresshappenstogether #bestteamwins
-
Graham Heieis explains how he came to be solving one of the world’s largest health burdens. Hear from Graham, in part five of Love Letters to Science. OUT NOW! Watch the short film here: https://bit.ly/3QOcQBV #ProgressHappensTogether #LoveLettersToScience #Abcam #ThePeopleBehindTheScience
-
To hit the research bullseye, you need precision. That’s why we optimize our recombinant antibodies to give you unrivaled specificity and consistency every time. https://lnkd.in/emKi-Un
-
“One of the best feelings in science is seeing new data… Something that hasn’t been discovered or shown by anyone else”. - Graham Heieis, EPISODE OUT NOW! Hear how Graham came to be solving one of the world’s largest health burdens. In abcam's new short film series, Love Letters to Science, part five launches with Graham’s story of how he fell in love with science. Watch the full episode here: https://bit.ly/3QOcQBV #ProgressHappensTogether #Abcam #LoveLettersToScience
-
April is Parkinson's Awareness Month, and we're spotlighting the incredible work of Nicole Polinksi and Elisia Clark, both scientists-turned-connectors at The Michael J. Fox Foundation for Parkinson's Research (MJFF). With a collaborative approach, they bridge the gap between researchers, tools, and funding to accelerate critical studies on Parkinson's disease. Read their story here: https://lnkd.in/eV4f6FVT #ParkinsonsMonth #ParkinsonsAwarenessMonth
-
📢 Exciting announcement! The Cell Cycle Conference returns on June 4 for our summer meeting at the Francis Crick Institute, London, and live-streamed for virtual attendees. Join us for an afternoon of insights into novel research findings, with a featured talk by Prof. Fumiko Esashi from the Sir William Dunn School of Pathology, University of Oxford. 📝 #CallforAbstracts: showcase your innovative research to a community of like-minded #cellcycle researchers. Short talk and poster opportunities are available to in-person attendees. Submit an abstract by May 17! https://bit.ly/3WeTidj
-
Today is International Day of Immunology! Check out this ground-breaking research from Graham Heieis & team on the immune response to helminths – one of the world’s most troubling parasitic infections. Dive deeper into Graham's passion for his work in his #LoveLetterstoScience film - out Wednesday! https://lnkd.in/e_xGH4pc #DOI2024 #Immunology
Metabolic heterogeneity of tissue-resident macrophages in homeostasis and during helminth infection - Nature Communications
nature.com